NEW YORK (GenomeWeb) – Med Fusion and GenomOncology have partnered to provide genomic profiles of patient tumors for treatment guidance and clinical trial enrollment, the companies said today.

Under the agreement, Med Fusion, a clinical service laboratory and clinical trials service organization based in Lewisville, Texas, will combine its solid tumor panels with GenomOncology's GO Clinical Workbench platform, a decision support tool that interprets tumor sequence data and translates molecular profiles into clinical reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.